Patents by Inventor Donato Del Camino

Donato Del Camino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATING DISORDERS
    Publication number: 20180133170
    Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.
    Type: Application
    Filed: June 30, 2017
    Publication date: May 17, 2018
    Inventors: Manfred Weigele, Jayhong A. Chong, Glenn R. Larsen, Neil J. Hayward, Amy Ripka, Howard Ng, Magdalene M. Moran, Christopher Fanger, Donato Del Camino, Steven P. Adams
  • INHIBITING TRPA1 FOR THE TREATMENT OF ASTHMA
    Publication number: 20140158116
    Abstract: This disclosure describes novel compounds and pharmaceutical compositions for inhibiting the TRPA1 ion channel and/or medical conditions related to TRPA1, such as asthma.
    Type: Application
    Filed: August 9, 2013
    Publication date: June 12, 2014
    Applicant: Cubist Pharmaceuticals, Inc.
    Inventors: Jayhong A. Chong, Scott C. Coleman, Rory Curtis, Donato del Camino, Yu Gui Gu, Qingyi Li, Blaise S. Lippa, Chester A. Metcalf, III, Magdalene M. Moran, Michael D. Ryan, Dong Zou
  • METHODS AND COMPOSITIONS FOR TREATING DISORDERS
    Publication number: 20130059869
    Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.
    Type: Application
    Filed: February 22, 2012
    Publication date: March 7, 2013
    Inventors: Howard Ng, Manfred Weigele, Magdalene Moran, Jayhong Chong, Christopher Fanger, Glenn R. Larsen, Donato Del Camino, Neil Hayward, Steven P. Adams, Amy Ripka
  • Methods and compositions for treating disorders
    Patent number: 8163761
    Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.
    Type: Grant
    Filed: June 23, 2008
    Date of Patent: April 24, 2012
    Assignee: Hydra Biosciences, Inc.
    Inventors: Howard Ng, Manfred Weigele, Magdalene Moran, Jayhong Chong, Christopher Fanger, Glenn R. Larsen, Donato Del Camino, Neil Hayward, Steven P. Adams, Amy Ripka
  • METHOD OF DETECTING A CANCER CELL BY ABERRANT EXPRESSION OF A HUMAN K+ ION CHANNEL
    Publication number: 20100021467
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Application
    Filed: June 9, 2009
    Publication date: January 28, 2010
    Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventors: Luis Angel Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Del Camino Fernandez-Miranda, Araceli Sanchez Perez, Rudiger Weseloh
  • METHODS AND COMPOSITIONS FOR TREATING DISORDERS
    Publication number: 20090143377
    Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.
    Type: Application
    Filed: June 23, 2008
    Publication date: June 4, 2009
    Inventors: Howard Ng, Manfred Weigele, Magdalene Moran, Jayhong Chong, Christopher Fanger, Glenn R. Larsen, Donato Del Camino, Neil Hayward, Steven P. Adams, Amy Ripka
  • Human K channel and prognosing applications thereof
    Patent number: 7364730
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: April 29, 2008
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften, E.V.
    Inventors: Luis A Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Del Camino Fernandez-Miranda, Araceli Sanchez Perez, Rudiger Weseloh
  • Human Kchannel and prognosing applications thereof
    Patent number: 7364845
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: April 29, 2008
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften, E.V.
    Inventors: Luis A Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Del Camino Fernandez-Miranda, Araceli Sanchez Perez, Rudiger Weseloh
  • Human Kchannel polypeptides
    Patent number: 7314914
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: January 1, 2008
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften, E.V.
    Inventors: Luis A Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Del Camino Fernandez-Miranda, Araceli Sanchez Perez, Rudiger Weseloh
  • Human K ion channel and therapeutic applications thereof
    Patent number: 7129207
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: October 31, 2006
    Assignee: Max-Planck-Gesellschaft zur Forderung Wissenschaften e.V.
    Inventors: Luis A Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Del Camino Fernandez-Miranda, Araceli Sanchez Perez, Rudiger Weseloh
  • Human K+ ion EAG channels
    Patent number: 6638736
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Grant
    Filed: October 23, 2000
    Date of Patent: October 28, 2003
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventors: Luis Angel Pardo-Fernández, Walter Stühmer, Synnöve Beckh, Andrea Brüggemann, Donato Del Camino Fernandez-Miranda, Araceli Sánchez Pérez, Rüdiger Weseloh
  • Novel human K+ ion channel and therapeutic applications thereof
    Publication number: 20030092120
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Application
    Filed: July 1, 2002
    Publication date: May 15, 2003
    Inventors: Luis Angel Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Del Camino Fernandez-Miranda, Araceli Sanchez Perez
  • Novel human K+ ion channel and therapeutic applications thereof
    Publication number: 20030087378
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Application
    Filed: July 1, 2002
    Publication date: May 8, 2003
    Inventors: Luis Angel Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Del Camino Fernandez-Miranda, Araceli Sanchez Perez, Rudiger Weseloh
  • Novel human K+ ion channel and therapeutic applications thereof
    Publication number: 20030087377
    Abstract: The present invention relates to a novel human K+ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Application
    Filed: July 1, 2002
    Publication date: May 8, 2003
    Inventors: Luis Angel Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Del Camino Fernandez-Miranda, Araceli Sanchez Perez, Rudiger Weseloh
  • Novel human Kchannel and therapeutic applications thereof
    Publication number: 20030077735
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Application
    Filed: July 1, 2002
    Publication date: April 24, 2003
    Inventors: Luis Angel Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Del Camino Fernandez-Miranda, Araceli Sanchez Perez, Rudiger Weseloh